pharmaphorum21d
GSK first to sign ‘open research’ deal with London’s Crick Institute
The inclusion of cancer in the new research partnership suggests GSK's continuing interest in the therapy area, despite its divestment of its marketed oncology portfolio to Novartis. Being first ...
The Harvard Crimson24d
Biopharma Giant GSK to Expand Research and Development Footprint in Cambridge
International biotechnology company GlaxoSmithKline is moving its ... step to strengthen its presence in the Greater Boston area. The research and development teams will relocate from Rockville ...
Fierce Pharma5d
GSK, Novartis, Lilly among Big Pharmas celebrating International Women’s Day 2025
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
GlaxoSmithKline (GSK) Gets a Hold from Barclays
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...